Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Aβ1-6: Toward safer and effective vaccines against Alzheimer's disease

Biochemical and Biophysical Research Communications

Volumn 336, Issue 1, 2005, Pages 84-92

  Kim, Hong Duck ^a,b   Maxwell, J Adam ^a,b   Kong, Fan Kun ^c   Tang, De Chu C ^c   Fukuchi, Ken Ichiro ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Vaxin Incorporated   (United States)

Author keywords

Adenovirus; Alzheimer's disease; Amyloid; Antibody; ELISA; GM CSF; Immunization; Self protein; Transgenic mice; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; ANTIBODY; IMMUNOGLOBULIN G1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFICACY; DRUG SAFETY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TANDEM REPEAT; TH2 CELL;

ADENOVIRIDAE; ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; ANIMALS; BASE SEQUENCE; CELL LINE; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; TANDEM REPEAT SEQUENCES;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 24344497384     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.044     Document Type: Article

References (31)

1. M.P. Lambert, K.L. Viola, B.A. Chromy, L. Chang, T.E. Morgan, J. Yu, D.L. Venton, G.A. Krafft, C.E. Finch, and W.L. Klein Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies J. Neurochem. 79 2001 595 605
2. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
3. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
4. C. Janus, J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, S.D. Schmidt, M.A. Chishti, P. Horne, D. Heslin, J. French, H.T. Mount, R.A. Nixon, M. Mercken, C. Bergeron, P.E. Fraser, P. George-Hyslop, and D. Westaway A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
5. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, J. Hardy, K. Duff, P. Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon, and G.W. Arendash A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
6. E. Check Nerve inflammation halts trial for Alzheimer's drug Nature 415 2002 462
7. J.A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat. Med. 9 2003 448 452
8. J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, L.C. Kirby, P. Jouanny, B. Dubois, L. Eisner, S. Flitman, B.F. Michel, M. Boada, A. Frank, and C. Hock Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization Neurology 61 2003 46 54
9. H.D. Kim, F.K. Kong, Y. Cao, T.L. Lewis, H. Kim, D.C. Tang, and K. Fukuchi Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain Neurosci. Lett. 370 2004 218 223
10. H.D. Kim, Y. Cao, F.K. Kong, K.R. Van Kampen, T.L. Lewis, Z. Ma, D.C. Tang, and K. Fukuchi Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF Vaccine 23 2005 2977 2986
11. J. McLaurin, R. Cecal, M.E. Kierstead, X. Tian, A.L. Phinney, M. Manea, J.E. French, M.H. Lambermon, A.A. Darabie, M.E. Brown, C. Janus, M.A. Chishti, P. Horne, D. Westaway, P.E. Fraser, H.T. Mount, M. Przybylski, and P. George-Hyslop Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis Nat. Med. 8 2002 1263 1269
12. T. Town, J. Tan, N. Sansone, D. Obregon, T. Klein, and M. Mullan Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42 Neurosci. Lett. 307 2001 101 104
13. D.H. Cribbs, A. Ghochikyan, V. Vasilevko, M. Tran, I. Petrushina, N. Sadzikava, D. Babikyan, P. Kesslak, T. Kieber-Emmons, C.W. Cotman, and M.G. Agadjanyan Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid Int. Immunol. 15 2003 505 514
14. C.T. Hsu, C.Y. Ting, C.J. Ting, T.Y. Chen, C.P. Lin, J. Whang-Peng, and J. Hwang Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats Cancer Res. 60 2000 3701 3705
15. K.I. Fukuchi, D.D. Kunkel, P.A. Schwartzkroin, K. Kamino, C.E. Ogburn, C.E. Furlong, and G.M. Martin Overexpression of a C-terminal portion of the beta-amyloid precursor protein in mouse brains by transplantation of transformed neuronal cells Exp. Neurol. 127 1994 253 264
16. C.T. Lee, S. Wu, I.F. Ciernik, H. Chen, S. Nadaf-Rahrov, D. Gabrilovich, and D.P. Carbone Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor Hum. Gene Ther. 8 1997 187 193
17. Z. Shi, M. Zeng, G. Yang, F. Siegel, L.J. Cain, K.R. Van Kampen, C.A. Elmets, and D.C. Tang Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines J. Virol. 75 2001 11474 11482
18. K. Fukuchi, D. Pham, M. Hart, L. Li, and J.R. Lindsey Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy Am. J. Pathol. 153 1998 1687 1693
19. K. Fukuchi, L. Ho, S.G. Younkin, D.D. Kunkel, C.E. Ogburn, R.C. LeBoeuf, C.E. Furlong, S.S. Deeb, D. Nochlin, J. Wegiel, H.M. Wisniewski, and G.M. Martin High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice Am. J. Pathol. 149 1996 219 227
20. J.L. Jankowsky, D.J. Fadale, J. Anderson, G.M. Xu, V. Gonzales, N.A. Jenkins, N.G. Copeland, M.K. Lee, L.H. Younkin, S.L. Wagner, S.G. Younkin, and D.R. Borchelt Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase Hum. Mol. Genet. 13 2004 159 170
21. E.T. Spooner, R.V. Desai, C. Mori, J.F. Leverone, and C.A. Lemere The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol Vaccine 21 2002 290 297
22. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr., L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
23. E.B. Lee, L.Z. Leng, V.M. Lee, and J.Q. Trojanowski Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis FEBS Lett. 579 2005 2564 2568
24. N. Tatsis, and H.C. Ertl Adenoviruses as vaccine vectors Mol. Ther. 10 2004 616 629
25. J.L. Boyer, G. Kobinger, J.M. Wilson, and R.G. Crystal Adenovirus-based genetic vaccines for biodefense Hum. Gene Ther. 16 2005 157 168
26. D.C. Tang, Z. Shi, and D.T. Curiel Vaccination onto bare skin Nature 388 1997 729 730
27. K.R. Van Kampen, Z. Shi, P. Gao, J. Zhang, K.W. Foster, D.T. Chen, D. Marks, C.A. Elmets, and D.C. Tang Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans Vaccine 23 2005 1029 1036
28. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, I. Lieberburg, R. Motter, M. Nguyen, F. Soriano, N. Vasquez, K. Weiss, B. Welch, P. Seubert, D. Schenk, and T. Yednock Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 2000 916 919
29. F. Bard, R. Barbour, C. Cannon, R. Carretto, M. Fox, D. Games, T. Guido, K. Hoenow, K. Hu, K. Johnson-Wood, K. Khan, D. Kholodenko, C. Lee, M. Lee, R. Motter, M. Nguyen, A. Reed, D. Schenk, P. Tang, N. Vasquez, P. Seubert, and T. Yednock Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology Proc. Natl. Acad. Sci. USA 100 2003 2023 2028
30. J.F. Leverone, E.T. Spooner, H.K. Lehman, J.D. Clements, and C.A. Lemere Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting" Vaccine 21 2003 2197 2206
31. C.A. Lemere, E.T. Spooner, J.F. Leverone, C. Mori, and J.D. Clements Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants Neurobiol. Aging 23 2002 991 1000